Research programme: Ebola virus vaccine - Soligenix/Hawaii Biotech/University of Hawaii
Latest Information Update: 20 Jul 2016
At a glance
- Originator Hawaii Biotech; Soligenix; University of Hawaii
- Class Viral vaccines
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Ebola virus infections
Most Recent Events
- 18 Jul 2016 Preclinical trials in Ebola virus infections in USA (Parenteral)
- 28 May 2015 Early research in Ebola virus infections in USA (Parenteral)